Sarolaner
QP53BE03 (WHO) | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
JSmol) | |
| |
| |
Sarolaner, sold under the brand name Simparica, is an
demodectic mange.[4]
Sarolaner is also a component of the
Sarolaner is also an ingredient in feline
References
- ^ "Approved in 2020: Drugs for human use". Health Canada. 26 July 2021. Retrieved 27 March 2024.
- ^ "Simparica". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
- PMID 26961590.
- ^ a b Gollakner R. "Sarolaner". vcahospitals.com. VCA Hospitals. Retrieved 26 June 2021.
- ^ "Simparica Trio". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
- ^ "FDA Approves Simparica Trio, a Combination Drug for Heartworm and Other Parasites". U.S. Food and Drug Administration (FDA). 2 March 2020. Retrieved 26 June 2021.
- ^ "Stronghold Plus". European Medicines Agency. Retrieved 12 December 2022.
- ^ "Revolution Plus". U.S. Food and Drug Administration (FDA). Retrieved 12 December 2022.
External links
- "Sarolaner". Drug Information Portal. U.S. National Library of Medicine.
 | This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |